Clinical Trials Directory

Trials / Completed

CompletedNCT00300443

Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
561 (actual)
Sponsor
Allergan · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess the safety and efficacy of bimatoprost in patients with glaucoma or ocular hypertension

Conditions

Interventions

TypeNameDescription
DRUGbimatoprost

Timeline

Start date
2005-12-01
Primary completion
2007-06-01
Completion
2007-06-01
First posted
2006-03-09
Last updated
2011-05-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00300443. Inclusion in this directory is not an endorsement.

Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension (NCT00300443) · Clinical Trials Directory